Oncternal Therapeutics Inc. buy me8
Start price
30.05.22
/
0%
€1.40
Target price
30.05.23
€1.70
Performance (%)
-19.36%
End price
11.06.22
€1.13
Summary
This prediction ended on 11.06.22 with a price of €1.13. The prediction for Oncternal Therapeutics Inc. disappointed with a performance of -19.36%. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Oncternal Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -0.654% | 1.989% | 14.984% |
| iShares Nasdaq 100 | 0.903% | 5.664% | 36.140% |
| iShares Nikkei 225® | -0.740% | -1.363% | 10.792% |
| iShares S&P 500 | -0.013% | 3.020% | 28.126% |
According to me8 what are the pros and cons of Oncternal Therapeutics Inc. for the foreseeable future?
Pros
Very capable Management
Could be worthwhile Investment >10% per year
Very good company culture
Leading role in innovation
Cons
Few uniques
Comments by me8 for this prediction
In the thread Oncternal Therapeutics Inc. diskutieren
Buy Oncternal Therapeutics Inc.
Kursziel gesetzt auf 1,0
Kursziel geändert auf 1,7
In the thread Trading Oncternal Therapeutics Inc.
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.